Medtronic plc [MDT] vs Dexcom [DXCM] Detailed Stock Comparison

Medtronic plc

NYSE
Loading...

Dexcom Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Medtronic plc wins in 12 metrics, Dexcom Inc. wins in 8 metrics, with 0 ties. Medtronic plc appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Medtronic plc Dexcom Inc. Better
P/E Ratio (TTM) 23.47 30.03 Medtronic plc
Price-to-Book Ratio 2.20 8.63 Medtronic plc
Debt-to-Equity Ratio 57.06 50.85 Dexcom Inc.
PEG Ratio -1.98 0.39 Dexcom Inc.
EV/EBITDA 13.43 19.85 Medtronic plc
Profit Margin (TTM) 13.00% 17.94% Dexcom Inc.
Operating Margin (TTM) 20.01% 25.64% Dexcom Inc.
EBITDA Margin (TTM) 20.01% 25.64% Dexcom Inc.
Return on Equity 9.39% 34.50% Dexcom Inc.
Return on Assets (TTM) 4.57% 8.89% Dexcom Inc.
Free Cash Flow (TTM) $5.19B $1.08B Medtronic plc
Dividend Yield 3.27% N/A N/A
1-Year Return -8.10% -8.07% Dexcom Inc.
Price-to-Sales Ratio (TTM) 3.04 5.10 Medtronic plc
Enterprise Value $126.74B $23.09B Medtronic plc
EV/Revenue Ratio 3.57 4.95 Medtronic plc
Gross Profit Margin (TTM) 63.83% 62.93% Medtronic plc
Revenue per Share (TTM) $28 $12 Medtronic plc
Earnings per Share (Diluted) $3.58 $2.05 Medtronic plc
Beta (Stock Volatility) 0.76 1.56 Medtronic plc
Short % of Float 1.33% 4.93% Medtronic plc

Medtronic plc vs Dexcom Inc. Stock Performance Analysis

Loading Price Chart...

MDT
DXCM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Medtronic plc0.22%-0.38%5.55%-8.91%-18.45%-16.31%
Dexcom Inc.-1.53%-3.13%20.43%11.88%12.92%11.54%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Medtronic plc-8.10%-10.04%-34.92%-4.68%110.00%59.60%
Dexcom Inc.-8.07%-42.07%-27.92%315.26%2,149.85%2,129.88%

Performance & Financial Health Analysis: Medtronic plc vs Dexcom Inc.

MetricMDTDXCM
Market Information
Market Cap i$107.58B$23.76B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i7,795,7304,652,604
90 Day Avg. Volume i7,987,3204,100,848
Last Close$80.38$74.22
52 Week Range$73.31 - $106.33$54.11 - $89.98
% from 52W High-24.41%-17.52%
All-Time High$135.89 (Sep 06, 2021)$164.86 (Nov 15, 2021)
% from All-Time High-40.85%-54.98%
Growth Metrics
Quarterly Revenue Growth0.09%0.13%
Quarterly Earnings Growth-0.12%0.76%
Financial Health
Profit Margin (TTM) i0.13%0.18%
Operating Margin (TTM) i0.20%0.26%
Return on Equity (TTM) i0.09%0.35%
Debt to Equity (MRQ) i57.0650.85
Cash & Liquidity
Book Value per Share (MRQ)$38.17$7.14
Cash per Share (MRQ)$6.53$5.19
Operating Cash Flow (TTM) i$7.29B$1.44B
Levered Free Cash Flow (TTM) i$4.07B$719.54M
Dividends
Last 12-Month Dividend Yield i3.27%N/A
Last 12-Month Dividend i$2.80N/A

Valuation & Enterprise Metrics Analysis: Medtronic plc vs Dexcom Inc.

MetricMDT (Apr 24, 2026)DXCM (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i23.4730.03
Forward P/E i13.8620.59
PEG Ratio i-1.980.39
Price to Sales (TTM) i3.045.10
Price to Book (MRQ) i2.208.63
Market Capitalization
Market Capitalization i$107.58B$23.76B
Enterprise Value i$126.74B$23.09B
Enterprise Value Metrics
Enterprise to Revenue i3.574.95
Enterprise to EBITDA i13.4319.85
Risk & Other Metrics
Beta i0.761.56
Book Value per Share (MRQ) i$38.17$7.14

Financial Statements Comparison: Medtronic plc vs Dexcom Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMDT (2025)DXCM (2025)
Revenue/Sales i33.54B4.66B
Cost of Goods Sold i11.63B1.86B
COGS % of Revenue i34.7%39.9%
Gross Profit i21.91B2.80B
Gross Margin i65.3%60.1%
Research & Development i2.73B599.10M
Operating Income (EBIT) i6.54B911.80M
Operating Margin i19.5%19.6%
EBITDA i9.80B1.36B
EBITDA Margin i29.2%29.1%
Pre-Tax Income i5.63B1.09B
Pre-Tax Income % of Revenue i16.8%23.3%
Income Tax i936.00M252.10M
Income Tax % of Revenue i2.8%5.4%
Net Income (Profit) i4.69B836.30M
Profit Margin i14.0%17.9%

Balance Sheet & Liquidity Metrics

MetricMDT (2025)DXCM (2025)
Cash & Equivalents i2.22B917.70M
Total Current Assets i23.81B4.03B
Total Current Assets % of Revenue i71.0%86.5%
Total Current Liabilities i12.88B2.14B
Total Current Liabilities % of Revenue i38.4%46.0%
Long-Term Debt i25.64B1.37B
Long-Term Debt % of Revenue i76.5%29.3%
Total Shareholders Equity i48.26B2.75B
Retained Earnings i31.48B2.43B
Retained Earnings % of Revenue i93.9%52.2%
Property, Plant & Equipment i7.16B77.40M

Cash Flow Statement Comparison

MetricMDT (2025)DXCM (2025)
Operating Cash Flow i6.71B1.48B
Operating Cash Flow % of Revenue i20.0%31.7%
Capital Expenditures i-1.86B-363.50M
Free Cash Flow i5.19B1.08B
FCF Margin i15.5%23.1%
Debt Repayment i-1.07B-1.21B
Common Stock Repurchase i-3.24B-500.00M

Short Interest & Institutional Ownership Analysis

MetricMDTDXCM
Shares Short i16.98M14.72M
Short Ratio i2.033.77
Short % of Float i1.33%4.93%
Shares Outstanding i1.28B384.80M
Float Shares i1.28B382.94M
% Held by Insiders i0.32%0.28%
% Held by Institutions i88.20%101.50%
% Held by Public i11.48%-1.78%

Dividend Analysis & Yield Comparison: Medtronic plc vs Dexcom Inc.

MetricMDTDXCM
Last 12-Month Dividend i$2.80N/A
Last 12-Month Dividend Yield i3.27%N/A
3-Year Avg Annual Dividend i$2.76N/A
3-Year Avg Dividend Yield i0.83%N/A
3-Year Total Dividends i$8.28N/A
Ex-Dividend DateMar 28, 2025N/A